Potential Mechanisms of Tunneling Nanotube Formation and Their Role in Pathology Spread in Alzheimer's Disease and Other Proteinopathies

• Published in: International journal of molecular sciences 2024-10, Vol.25 (19), p.10797
• Main Authors: Kotarba, Szymon, Kozłowska, Marta, Scios, Małgorzata, Saramowicz, Kamil, Barczuk, Julia, Granek, Zuzanna, Siwecka, Natalia, Wiese, Wojciech, Golberg, Michał, Galita, Grzegorz, Sychowski, Grzegorz, Majsterek, Ireneusz, Rozpędek-Kamińska, Wioletta
• Format: Article
• Language: English
• Subjects: Advertising executives; alpha-Synuclein - metabolism; Alzheimer Disease - metabolism; Alzheimer Disease - pathology; Alzheimer's disease; Amino acids; Amyloid beta-Peptides - metabolism; Animals; beta-amyloid; Brain; Brain - metabolism; Brain - pathology; Cell Membrane Structures; Cognitive ability; Dementia; Development and progression; Disease; Diseases; DNA-Binding Proteins - metabolism; Enzymes; etiopathogenesis; Health aspects; Humans; Hypotheses; Muscle proteins; Nanotubes; Neurons; Neurons - metabolism; Neurons - pathology; Oxidative stress; Pathogenesis; Pathology; Pathophysiology; Physiological aspects; Protein binding; Proteins; Review; Tau proteins; tau Proteins - metabolism; tunneling nanotubes
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms251910797

Alzheimer's disease (AD) is the most common type of dementia worldwide. The etiopathogenesis of this disease remains unknown. Currently, several hypotheses attempt to explain its cause, with the most well-studied being the cholinergic, beta-amyloid (Aβ), and Tau hypotheses. Lately, there has been increasing interest in the role of immunological factors and other proteins such as alpha-synuclein (α-syn) and transactive response DNA-binding protein of 43 kDa (TDP-43). Recent studies emphasize the role of tunneling nanotubes (TNTs) in the spread of pathological proteins within the brains of AD patients. TNTs are small membrane protrusions composed of F-actin that connect non-adjacent cells. Conditions such as pathogen infections, oxidative stress, inflammation, and misfolded protein accumulation lead to the formation of TNTs. These structures have been shown to transport pathological proteins such as Aβ, Tau, α-syn, and TDP-43 between central nervous system (CNS) cells, as confirmed by in vitro studies. Besides their role in spreading pathology, TNTs may also have protective functions. Neurons burdened with α-syn can transfer protein aggregates to glial cells and receive healthy mitochondria, thereby reducing cellular stress associated with α-syn accumulation. Current AD treatments focus on alleviating symptoms, and clinical trials with Aβ-lowering drugs have proven ineffective. Therefore, intensifying research on TNTs could bring scientists closer to a better understanding of AD and the development of effective therapies.